Supernus Pharmaceuticals Inc (NASDAQ:SUPN)

39.40
Delayed Data
As of Feb 23
 +0.95 / +2.47%
Today’s Change
24.65
Today|||52-Week Range
50.05
-1.13%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
AssetsCash33.0M36.4M34.2M66.4M
 
 
 
 
 
Short Term Investment Cash-7.3M3.4M-2.2M32.9M
 
 
 
 
 
Cash & Short Term Investments82.2M74.3M62.2M90.1M
 
 
 
 
 
 
ReceivablesReceivables5.5M17.3M25.9M41.5M
 
 
 
 
 
 
InventoriesInventories7.2M13.4M12.6M16.8M
 
 
 
 
 
 
Current AssetsOther Current Assets2.1M3.8M5.3M3.0M
 
 
 
 
 
Current Assets96.9M108.9M106.0M151.4M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross8.1M8.7M10.8M12.4M
 
 
 
 
 
Depreciation-5.6M-6.3M-7.0M-8.1M
 
 
 
 
 
Intangible Assets1.2M225.0K976.0K16.5M
 
 
 
 
 
Other Assets2.8M6.0M23.6M36.4M
 
 
 
 
 
Total Assets111.0M137.5M188.7M309.6M
 
 
 
 
 
 
LiabilitiesAccounts Payable3.1M1.9M4.3M8.1M
 
 
 
 
 
Short Term Debt0.000.000.003.1M
 
 
Accrued Expenses9.5M19.1M43.8M60.2M
 
 
 
 
 
Other Current Liabilities18.2M19.8M44.3M60.4M
 
 
 
 
 
Other Liabilities26.4M27.5M56.1M80.7M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt34.4M26.9M7.2M31.5M
 
 
 
 
 
Deferred Taxes0.000.000.00-41.7M
 
 
Other Liabilities15.3M10.4M5.2M4.1M
 
 
 
 
 
Total Liabilities77.5M66.2M69.9M117.8M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity33.5M71.4M118.9M191.8M
 
 
 
 
 
Total Shareholder Equity33.5M71.4M118.9M191.8M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding40.0M43.0M49.0M50.0M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.